Redtop Grass Allergy: The FDA-Standardized Grass Nobody Has Heard Of

Redtop (Agrostis gigantea) is a cool-season perennial Pooideae grass named for the reddish-purple tint of its flower heads. It is found throughout the United States in wet meadows, roadsides, and old lawns where it was historically planted as a pasture and lawn grass before being displaced by modern cultivars. It causes allergies through the same IgE-mediated mechanism as all Pooideae grasses: its pollen contains Group 1 beta-expansin and Group 5 ribonuclease-like allergens that trigger sensitization in susceptible individuals. Redtop is notable for being one of only eight grasses with an FDA-standardized extract (g9, 100,000 BAU/mL) — a level of regulatory recognition that reflects its genuine allergenic significance even though its name is rarely recognized by patients.

Yes, Timothy grass immunotherapy — whether delivered as the FDA-approved Grastek SLIT tablet, the Oralair 5-grass tablet, custom SLIT drops, or traditional allergy shots — provides approximately 95 percent cross-reactive coverage for redtop grass through the shared Pooideae Group 1 and Group 5 allergen pathway. Patients already on Timothy-based immunotherapy do not need to modify their treatment or add redtop extract separately. This is the Pooideae cross-reactivity principle at its most reassuring: a single Timothy representative covers all sweet grass species in a single treatment formulation. The only management consideration unique to redtop is extending medications through August to cover its slightly later pollen window compared to Timothy.

Yes, golf courses are a significant and specific Agrostis pollen exposure environment. Creeping bentgrass (Agrostis stolonifera) is the primary turf grass used on greens and fairways of golf courses across all 50 states. While intensely mowed greens have reduced pollen output, roughs, surrounds, and unmaintained areas where bentgrass grows taller produce substantial pollen during June through August. Golfers who play multiple rounds per week during summer accumulate meaningful cumulative Agrostis exposure. Grass-allergic golfers who notice that their allergy symptoms are disproportionately worse on course days compared to other outdoor days may be experiencing specific Agrostis bentgrass sensitization driving golf-associated hay fever.

Redtop grass pollen peaks from June through August, with the heaviest release in June and July across most of the United States. This timing is approximately 2 to 4 weeks later than the Timothy grass peak of late May through early July, extending the Pooideae grass allergy season slightly into the summer months. In southern states, redtop pollination may begin in May; in northern regions, the season may not begin until late June and can extend into early September. The key practical implication is that patients who expect grass season to end in late June or early July may be surprised by continued Agrostis-driven symptoms through August, particularly if they have been playing golf, living near old meadows, or spending time in environments where Agrostis species are common.

Redtop (Agrostis gigantea) and creeping bentgrass (Agrostis stolonifera) are both species within the genus Agrostis and share essentially identical allergen profiles through their common Pooideae Group 1 and Group 5 proteins. Patients sensitized to one will cross-react with the other. The key practical difference is habitat: redtop grows in wet meadows, old lawns, roadsides, and pastures and pollinates as a taller plant; creeping bentgrass has been specifically bred for its low-growing, dense, stolon-forming habit ideal for golf course greens and fairways, where it is maintained at cut heights of 0.10 to 0.15 inches and covers essentially every golf course in the United States. Both species produce pollen from June through August. From an allergy management perspective, they are clinically interchangeable.

Redtop (Agrostis gigantea) and perennial ryegrass (Lolium perenne) are different species but both belong to subfamily Pooideae and share approximately 90 percent Group 1 allergen sequence identity and Group 5 cross-reactivity. Patients sensitized to one will almost certainly cross-react with the other through the standard Pooideae allergen framework. The meaningful distinction between them is geographic and ecological rather than immunological: ryegrass is the dominant grass in the Pacific Northwest's Willamette Valley where grass seed production creates some of the highest grass pollen concentrations in the world, while redtop is distributed throughout the US in meadow and old lawn habitats. Both respond to the same Timothy-based immunotherapy through Pooideae cross-reactivity.

Yes, redtop grass pollen can trigger asthma exacerbations in sensitized patients with underlying asthma. The mechanism is identical to that of all grass-pollen-triggered asthma: inhaled pollen activates mast cells in the bronchial mucosa through IgE cross-linking, producing bronchoconstriction, airway inflammation, and increased mucus production. In thunderstorm conditions, Pooideae grass pollen grains can undergo osmotic rupture and release sub-pollen starch granules small enough to reach the alveolar region — the mechanism of thunderstorm asthma events. The June through August redtop season extends the period of asthma risk slightly beyond the Timothy and ryegrass peak. All asthmatic grass-allergic patients should have optimized controller medication and a written asthma action plan in place before the start of grass season in May.

Redtop grass allergy is typically diagnosed as part of the standard Pooideae grass sensitization evaluation rather than as an isolated Agrostis-specific test. A positive skin prick test or specific IgE result for Timothy grass (g6, the Pooideae reference standard) confirms sensitization that covers redtop through ~95 percent cross-reactivity. Component-resolved testing for Phl p 5 (Pooideae Group 5 allergen) is the most informative molecular confirmation, as a positive Phl p 5 result identifies full sweet grass sensitization extending to all Pooideae species including redtop and Agrostis bentgrass. Redtop-specific IgE testing (g9, the FDA-standardized extract) is available but rarely adds clinical value beyond what Timothy testing already provides in the context of the Pooideae cross-reactivity framework.

No, redtop grass allergy does not require any treatment modifications beyond standard Pooideae grass allergy management. The two adaptations worth noting are calendar-related: first, nasal corticosteroids and antihistamines should be continued through August to cover the later-than-Timothy redtop season; second, golfers should implement course-specific strategies during June through August to manage the concentrated Agrostis bentgrass exposure at golf courses. For immunotherapy, Timothy-based SLIT or SCIT already covers redtop completely. Custom SLIT drops formulated with Timothy grass provide the same cross-reactive benefit while enabling multi-allergen combinations for patients with co-existing tree, weed, or dust mite sensitivities.